Core Insights - The company reported a revenue of RMB 4.525 billion for the first half of 2025, a decrease of 9.07% year-on-year [1] - The profit attributable to the company's owners was RMB 340 million, down 21.76% year-on-year, with earnings per share at RMB 0.27 [1] - The decline in net profit is primarily attributed to a decrease in average medical insurance fees, which affected the operating profits of member medical institutions [1] Financial Performance - The hospital business segment generated revenue of RMB 4.259 billion, a decrease of 7.4% year-on-year [1] - The number of outpatient and emergency visits increased by 1.0% to approximately 5.1 million, while inpatient visits decreased by 3.9% to approximately 270,000 [1] - Average revenue per outpatient and inpatient visit declined by 5.8% due to the decrease in average medical insurance fees [1] - The gross profit for the hospital business segment was RMB 670 million, down 27.4%, with a gross margin of 15.7%, compared to 20.1% in the same period last year [1] - The profit for the hospital business segment was RMB 255 million, a decrease of 51.1% year-on-year [1] Other Business Segments - Other business revenue was RMB 266 million, a decrease of 29.3% year-on-year, while segment profit increased by 96.9% to RMB 292 million [2] - After excluding a one-time management fee and compensation of approximately RMB 210 million from the Yanhua IOT agreement, the segment profit was RMB 86 million, down 42.1% year-on-year [2] - The reduction in IOT business scale contributed to the decline in profit contribution during the reporting period [2]
华润医疗(01515.HK)上半年纯利跌21.76%至3.4亿元 自有医院诊疗门急诊量同比增长1.0%